Redfin Report: Rents Post First Annual Decline in Three Years
The median asking rent fell 0.4% in March to the lowest level in 13 months….
The median asking rent fell 0.4% in March to the lowest level in 13 months….
Now demoing at the new site facility, Qunnect also announces the commercial launch of QU-Source,…
PALO ALTO, Calif.–(BUSINESS WIRE)–#AI—SambaNova Systems, the company first to market with pre-trained foundation models that…
PASADENA, Calif.–(BUSINESS WIRE)–Heliogen, Inc. (“Heliogen” or the “Company”) (NYSE: HLGN), a leading provider of AI-enabled…
Conventional throughput volumes for the first quarter of 2023 within previously forecasted 69,000-72,000 bpd range,…
NKGen Biotech, Inc. (“NKGen”), a clinical stage Natural Killer (NK) cell therapy company, has entered…
PALO ALTO, Calif., April 14, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a…
Burlington, Ontario–(Newsfile Corp. – April 14, 2023) – Evertz Technologies Limited (TSX: ET) (“Evertz”) a…
PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ”, “VIQ Solutions” or the “Company”) (TSX and Nasdaq: VQS),…
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT), the leader in enabling the…
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE: WFC) has released its first quarter 2023 financial…
IRVINE, Calif.–(BUSINESS WIRE)–#AI—Immunis, Inc., a private biotechnology company developing a novel treatment for age and…
For the nine months ended February 28, 2023 vs. the same period in 2022, revenues,…
For the nine months ended February 28, 2023 vs. the same period in 2022, revenues,…
New research demonstrates the value of genomic and epigenomic methylation sequencing capabilities of Predicine liquid…
New research demonstrates the value of genomic and epigenomic methylation sequencing capabilities of Predicine liquid…
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”)…
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”)…
First clinical results to be presented at the AACR Annual Meeting 2023 showed 23ME-00610 demonstrated…
JENA, Germany, April 14, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a…